Home » Caprotec Raises $1.4M in Series B Round

Caprotec Raises $1.4M in Series B Round

May 09, 2011

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – German firm Caprotec Bioanalytics today announced it has raised €1 million ($1.4 million) in a Series B round.

The second closing brings the total amount raised in the round to €5 million in equity, Caprotec said. The company announced it had raised €4 million in the Series B round last year.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

Here We Are Again

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

In the Pink

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

All Tied Up in a Bow

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

This Week in PNAS

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.

What's Popular?

In Proteomics & Protein Research

  1. Pan-Cancer Mutation Study Identifies Protein Kinases Key to Tumor Suppression

    Premium

  2. Freenome, Biognosys Partner on Early Cancer Detection

  3. Copenhagen Team IDs Protein Complex Key to DNA Damage Repair

    Premium

  4. Top Down Proteomics Identifies Protein-Level Effects of KRAS Mutations in Colorectal Cancer

    Premium

  5. Waters Q1 Revenues Up 7 Percent

Sponsorships

Privacy Policy.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.